○Michihiro Satoh^1,2, Tomoko Muroya^1,2,3, Takahisa Murakami^1,2, Taku Obara^2,4, Kei Asayama^5,6, Takayoshi Ohkubo^5,6, Yutaka Imai⁶, Hirohito Metoki^1,2,6 (1. Med. Tohoku Medical and Pharmaceutical Univ., 2. ToMMo. Tohoku Univ., 3. Izumi Hospital., 4. Pharm. Tohoku Univ Hosp., 5. Med. Teikyo Univ., 6. Tohoku Institute for Management of BP)

○Yukina Yoshimura¹, Yuichi Muraki¹, Ryou Inose¹ (1. Kyoto Pharm Univ.)

○Junko Tomida¹, Masahiro Hirata², Mao Ichihara², Chiyo Yoshiyama², Naomi Iihara² (1. Graduate Pharm Sci, Tokushima Bunri Univ., 2. Kagawa Pharm, Tokushima Bunri Univ.)

○Ayumi Noda¹, Keiko Ogawa¹, Rumiko Hosoki¹ (1. Grad. Sch. Pharm. Sci., Ritsumeikan Univ.)

○Hinako Suzuki¹, Kairi Hosaka¹, Ryoko Sakai¹, Manabu Akazawa¹ (1. Department of Public Health and Epidemiology, Meiji Pharmaceutical University)

○Kasumi Morimoto¹, Ryoko Sakai¹, Manabu Akazawa¹ (1. Meiji Pharmaceutical University )

○Chie Takada¹, Yuki Takumoto^1,2, Manabu Akazawa¹ (1. Meiji Pharmaceutial Univ., 2. National Institute of Public Health)